SZSE:300702 (China)
Â
Class A
Â¥
15.85
(-0.56%)
Jan 16
Business Description
Zhejiang Tianyu Pharmaceutical Co Ltd
ISIN : CNE1000034X1
Share Class Description:
SZSE:300702: Class ACompare
Compare
Traded in other countries / regions
300702.China IPO Date
2017-09-19Description
Zhejiang Tianyu Pharmaceutical Co Ltd is the pharmaceutical manufacturing company. Its main business is the development, production and sales of active pharmaceutical ingredients and intermediates. The products mainly include antihypertensive drug and intermediates, anti-asthma drug raw materials and intermediates, antiviral drug intermediates. Its products are well sold in domestic and overseas markets.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.29 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.49 | |||||
| Debt-to-EBITDA | 12.49 | |||||
| Interest Coverage | 3.58 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.06 | |||||
| Beneish M-Score | -2.81 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2.4 | |||||
| 3-Year EBITDA Growth Rate | -23.6 | |||||
| 3-Year EPS without NRI Growth Rate | -53.6 | |||||
| 3-Year Book Growth Rate | -2.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 72.61 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 11.41 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.44 | |||||
| 9-Day RSI | 36.67 | |||||
| 14-Day RSI | 39.11 | |||||
| 6-1 Month Momentum % | 9.56 | |||||
| 12-1 Month Momentum % | -5.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.15 | |||||
| Quick Ratio | 0.43 | |||||
| Cash Ratio | 0.19 | |||||
| Days Inventory | 411.61 | |||||
| Days Sales Outstanding | 63.28 | |||||
| Days Payable | 186.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.31 | |||||
| Dividend Payout Ratio | 0.27 | |||||
| Forward Dividend Yield % | 0.31 | |||||
| 5-Year Yield-on-Cost % | 0.31 | |||||
| 3-Year Average Share Buyback Ratio | -2 | |||||
| Shareholder Yield % | -2.28 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 35.79 | |||||
| Operating Margin % | 7.68 | |||||
| Net Margin % | 1.68 | |||||
| FCF Margin % | 9.2 | |||||
| ROE % | 1.24 | |||||
| ROA % | 0.69 | |||||
| ROIC % | 2.15 | |||||
| 3-Year ROIIC % | -22.06 | |||||
| ROC (Joel Greenblatt) % | 3.29 | |||||
| ROCE % | 3.63 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 132.08 | |||||
| Forward PE Ratio | 25.16 | |||||
| PE Ratio without NRI | 86.61 | |||||
| Shiller PE Ratio | 25.56 | |||||
| PS Ratio | 2.14 | |||||
| PB Ratio | 1.56 | |||||
| Price-to-Tangible-Book | 1.79 | |||||
| Price-to-Free-Cash-Flow | 23.68 | |||||
| Price-to-Operating-Cash-Flow | 13.13 | |||||
| EV-to-EBIT | 49.27 | |||||
| EV-to-EBITDA | 49.27 | |||||
| EV-to-Revenue | 2.61 | |||||
| EV-to-FCF | 28.17 | |||||
| Price-to-Projected-FCF | 10.86 | |||||
| Price-to-Graham-Number | 2.62 | |||||
| Price-to-Net-Current-Asset-Value | 52.83 | |||||
| Earnings Yield (Greenblatt) % | 2.03 | |||||
| FCF Yield % | 4.33 | |||||
| Forward Rate of Return (Yacktman) % | 1.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhejiang Tianyu Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,594.521 | ||
| EPS (TTM) (Â¥) | 0.12 | ||
| Beta | 0.96 | ||
| Volatility % | 42.32 | ||
| 14-Day RSI | 39.11 | ||
| 14-Day ATR (Â¥) | 0.529224 | ||
| 20-Day SMA (Â¥) | 16.618 | ||
| 12-1 Month Momentum % | -5.76 | ||
| 52-Week Range (Â¥) | 13.16 - 21.45 | ||
| Shares Outstanding (Mil) | 347.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhejiang Tianyu Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhejiang Tianyu Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zhejiang Tianyu Pharmaceutical Co Ltd Frequently Asked Questions
What is Zhejiang Tianyu Pharmaceutical Co Ltd(SZSE:300702)'s stock price today?
The current price of SZSE:300702 is ¥15.85. The 52 week high of SZSE:300702 is ¥21.45 and 52 week low is ¥13.16.
When is next earnings date of Zhejiang Tianyu Pharmaceutical Co Ltd(SZSE:300702)?
The next earnings date of Zhejiang Tianyu Pharmaceutical Co Ltd(SZSE:300702) is .
Does Zhejiang Tianyu Pharmaceutical Co Ltd(SZSE:300702) pay dividends? If so, how much?
The Dividend Yield %  of Zhejiang Tianyu Pharmaceutical Co Ltd(SZSE:300702) is 0.31% (As of Today), Highest Dividend Payout Ratio of Zhejiang Tianyu Pharmaceutical Co Ltd(SZSE:300702) was 0.6. The lowest was 0.05. And the median was 0.13. The  Forward Dividend Yield % of Zhejiang Tianyu Pharmaceutical Co Ltd(SZSE:300702) is 0.31%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers